Literature DB >> 21107604

Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S).

Jin-yan Liu1, Qiang Li, Ting-ting Chen, Xia Guo, Jiao Ge, Li-xing Yuan.   

Abstract

UNLABELLED: Hyper IgE syndrome (HIES) is a rare primary immunodeficiency disorder, characterized by eczema, recurrent skin and lung infections, and significantly elevated serum IgE level. It was previously diagnosed based on clinical manifestations and laboratory markers that were not specific to the disease. Recent studies have demonstrated that mutations in signal transducer and activator of transcription 3 (STAT3) cause the autosomal dominant or sporadic HIES, which make the disease definitively characterized at molecular level. Here, we reported a 3-year old Chinese boy with neonatal-onset rash and multiple serious Staphylococcus aureus infections including recurrent skin abscesses, liver abscess, sepsis, and destructive pulmonary infection (pneumonia, multiple pulmonary abscesses, pyopneumothorax, and finally, pneumatocele). Genetic study revealed a heterozygous mutation in exon 21 of STAT3 gene (g.66583 A > C, c.1970A > C) in the boy, which resulted in a substitution of tyrosine at the amino acid position 657 to serine (p.Y657S) in the Src homology 2 (SH2) domain of STAT3. Functional prediction with bioinformatics programs of the Sorting Intolerant from Tolerant (SIFT) and the Polymorphism Phenotyping (PolyPhen) reported "deleterious (SIFT score 0.02)" and "probably damaging (PSIC score difference 2.94)" values, respectively. Further study of family members revealed that neither his parents, nor his twin brother carried the mutation, indicating the mutation was likely to occur de novo in our patient.
CONCLUSION: The mutation,p.Y657S,in SH2 domain of STAT3 is a disease-causing mutation in the boy with HIES.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21107604     DOI: 10.1007/s00431-010-1349-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  21 in total

1.  Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci.

Authors:  Vera Sass; Tanja Schneider; Miriam Wilmes; Christian Körner; Alessandro Tossi; Natalia Novikova; Olga Shamova; Hans-Georg Sahl
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

2.  Job's Syndrome. Recurrent, "cold", staphylococcal abscesses.

Authors:  S D Davis; J Schaller; R J Wedgwood
Journal:  Lancet       Date:  1966-05-07       Impact factor: 79.321

Review 3.  Hyperimmunoglobulin E syndrome and tyrosine kinase 2 deficiency.

Authors:  Yoshiyuki Minegishi; Hajime Karasuyama
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-12

Review 4.  Hyper-IgE syndrome.

Authors:  Yoshiyuki Minegishi
Journal:  Curr Opin Immunol       Date:  2009-08-28       Impact factor: 7.486

5.  Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity.

Authors:  Eleonore D Renner; Jennifer M Puck; Steven M Holland; Markus Schmitt; Michael Weiss; Michael Frosch; Markus Bergmann; Joie Davis; Bernd H Belohradsky; Bodo Grimbacher
Journal:  J Pediatr       Date:  2004-01       Impact factor: 4.406

6.  Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups.

Authors:  Hong Jiao; Beáta Tóth; Melinda Erdos; Ingegerd Fransson; Eva Rákóczi; István Balogh; Zoltán Magyarics; Beáta Dérfalvi; Gabriella Csorba; Anna Szaflarska; Andre Megarbane; Carlo Akatcherian; Ghassan Dbaibo; Eva Rajnavölgyi; Lennart Hammarström; Juha Kere; Gérard Lefranc; László Maródi
Journal:  Mol Immunol       Date:  2008-08-15       Impact factor: 4.407

7.  Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.

Authors:  Joshua D Milner; Jason M Brenchley; Arian Laurence; Alexandra F Freeman; Brenna J Hill; Kevin M Elias; Yuka Kanno; Christine Spalding; Houda Z Elloumi; Michelle L Paulson; Joie Davis; Amy Hsu; Ava I Asher; John O'Shea; Steven M Holland; William E Paul; Daniel C Douek
Journal:  Nature       Date:  2008-03-12       Impact factor: 49.962

Review 8.  Insights into the role of STAT3 in human lymphocyte differentiation as revealed by the hyper-IgE syndrome.

Authors:  Stuart G Tangye; Matthew C Cook; David A Fulcher
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

9.  Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome.

Authors:  Ellen D Renner; Stacey Rylaarsdam; Stephanie Anover-Sombke; Anita L Rack; Janine Reichenbach; John C Carey; Qili Zhu; Annette F Jansson; Julia Barboza; Lena F Schimke; Mark F Leppert; Melissa M Getz; Reinhard A Seger; Harry R Hill; Bernd H Belohradsky; Troy R Torgerson; Hans D Ochs
Journal:  J Allergy Clin Immunol       Date:  2008-07       Impact factor: 10.793

10.  Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.

Authors:  Cristina Woellner; E Michael Gertz; Alejandro A Schäffer; Macarena Lagos; Mario Perro; Erik-Oliver Glocker; Maria C Pietrogrande; Fausto Cossu; José L Franco; Nuria Matamoros; Barbara Pietrucha; Edyta Heropolitańska-Pliszka; Mehdi Yeganeh; Mostafa Moin; Teresa Español; Stephan Ehl; Andrew R Gennery; Mario Abinun; Anna Breborowicz; Tim Niehues; Sara Sebnem Kilic; Anne Junker; Stuart E Turvey; Alessandro Plebani; Berta Sánchez; Ben-Zion Garty; Claudio Pignata; Caterina Cancrini; Jiri Litzman; Ozden Sanal; Ulrich Baumann; Rosa Bacchetta; Amy P Hsu; Joie N Davis; Lennart Hammarström; E Graham Davies; Efrem Eren; Peter D Arkwright; Jukka S Moilanen; Dorothee Viemann; Sujoy Khan; László Maródi; Andrew J Cant; Alexandra F Freeman; Jennifer M Puck; Steven M Holland; Bodo Grimbacher
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

View more
  7 in total

Review 1.  Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.

Authors:  Jing Wu; Ji Chen; Zhi-Qing Tian; Hao Zhang; Ruo-Lan Gong; Tong-Xin Chen; Li Hong
Journal:  J Clin Immunol       Date:  2017-02-14       Impact factor: 8.317

Review 2.  STAT3 activation in infection and infection-associated cancer.

Authors:  Rong Lu; Yong-Guo Zhang; Jun Sun
Journal:  Mol Cell Endocrinol       Date:  2017-02-20       Impact factor: 4.102

3.  Recurrent Skin and Lung Infections in Autosomal Dominant Hyper IgE Syndrome with Transactivation Domain STAT3 Mutation.

Authors:  Chad J Cooper; Sarmad Said; German T Hernandez
Journal:  Case Reports Immunol       Date:  2014-03-05

4.  Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome?

Authors:  Rajiva de Silva; Dhanushka Dasanayake; Manouri Senanayake; Ramya Ediriweera; Savithri Dias; Chandima Karunatilleke; Karen Brocas; Fariba Tahami; Suranjith Seneviratne
Journal:  Allergy Asthma Clin Immunol       Date:  2018-11-02       Impact factor: 3.406

5.  Genetic Interactions of STAT3 and Anticancer Drug Development.

Authors:  Bingliang Fang
Journal:  Cancers (Basel)       Date:  2014-03-06       Impact factor: 6.639

Review 6.  Structural Implications of STAT3 and STAT5 SH2 Domain Mutations.

Authors:  Elvin D de Araujo; Anna Orlova; Heidi A Neubauer; Dávid Bajusz; Hyuk-Soo Seo; Sirano Dhe-Paganon; György M Keserű; Richard Moriggl; Patrick T Gunning
Journal:  Cancers (Basel)       Date:  2019-11-08       Impact factor: 6.639

7.  Dedicator of cytokinesis 8 deficiency and hyperimmunoglobulin E syndrome: A case report.

Authors:  Zhaojun Wang; Yanan Zhang; Gang Li; Lingyan Huang; Juan Chen
Journal:  Medicine (Baltimore)       Date:  2022-02-04       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.